Literature DB >> 24060877

In vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and sulfonamides in France.

Sirwan Muhammed Ameen1, Michel Drancourt.   

Abstract

Five type strains and 55 Mycobacterium tuberculosis complex clinical isolates were found resistant to trimethoprim with a MIC of >200 mg/liter and susceptible to both sulfadiazine and cotrimoxazole with a MIC90 of 10 mg/liter. Two M. canettii isolates uniquely yielded silent mutations C156 → T and G238 → C in the folP1 gene. Combined with scarce published data, these data indicate that sulfamides could be considered alternative antituberculous antibiotics.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24060877      PMCID： PMC3837923          DOI： 10.1128/AAC.01683-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  The biosynthesis of folic acid. II. Inhibition by sulfonamides.

Authors:  G M BROWN
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

2.  Mycobacterium tuberculosis and sulfamethoxazole susceptibility.

Authors:  Wendy Ong; Aina Sievers; David E Leslie
Journal:  Antimicrob Agents Chemother       Date:  2010-06       Impact factor: 5.191

Review 3.  Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.

Authors:  Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

4.  Tuberculosis and trimethoprim-sulfamethoxazole.

Authors:  Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Serum concentration of co-trimoxazole during a high-dosage regimen.

Authors:  Sirwan Muhammed Ameen; Jean-Marc Rolain; Marie-Noelle Le Poullain; Véronique Roux; Didier Raoult; Michel Drancourt
Journal:  J Antimicrob Chemother       Date:  2013-10-11       Impact factor: 5.790

6.  Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.

Authors:  Michaela Projahn; Claudio U Köser; Susanne Homolka; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 7.  Drug repositioning in the treatment of malaria and TB.

Authors:  Alexis Nzila; Zhenkun Ma; Kelly Chibale
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

8.  Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan.

Authors:  Tsi-Shu Huang; Calvin M Kunin; Bo-Shiun Yan; Yao-Shen Chen; Susan Shin-Jung Lee; Wan Syu
Journal:  J Antimicrob Chemother       Date:  2011-11-29       Impact factor: 5.790
  8 in total
  9 in total

Review 1.  Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors:  Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

2.  Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

Authors:  Joseph S Cavanaugh; Ruwen Jou; Mei-Hua Wu; Tracy Dalton; Ekaterina Kurbatova; Julia Ershova; J Peter Cegielski
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

3.  Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Authors:  L Davies Forsman; T Schön; U S H Simonsson; J Bruchfeld; M Larsson; P Juréen; E Sturegård; C G Giske; K Ängeby
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

Review 4.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

5.  Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.

Authors:  Divakar Sharma; Yogesh K Dhuriya; Nirmala Deo; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-12-11       Impact factor: 5.640

6.  Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Authors:  Martin Krátký; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

7.  Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data.

Authors:  Lionel Almeras; Leonardo K Basco; Cheikh Sokhna; Stéphane Ranque; Philippe Parola; Christian Devaux; Philippe Brouqui; Michel Drancourt; Bruno Pradines
Journal:  New Microbes New Infect       Date:  2018-07-04

8.  Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity.

Authors:  Martin Krátký; Magdaléna Dzurková; Jiří Janoušek; Klára Konečná; František Trejtnar; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-09-19       Impact factor: 4.411

9.  A case of multidrug-resistant Mycobacterium simiae in an elderly woman.

Authors:  Hadi Lotfi; Ehsan Aryan; Mojtaba Sankian; Zahra Meshkat; Ahmad Khalifeh Soltani; Amir Hooshang Alvandi; Hadi Farsiani
Journal:  Respirol Case Rep       Date:  2021-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.